These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1840228)

  • 61. Does ondansetron attenuate amphetamine-induced behaviour in human volunteers?
    Silverstone PH; Johnson B; Cowen PJ
    Psychopharmacology (Berl); 1992; 107(1):140-1. PubMed ID: 1534176
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!
    Barnes NM
    Gut; 2005 Aug; 54(8):1056-7. PubMed ID: 16009677
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent advances in the electrophysiological characterization of 5-HT3 receptors.
    Peters JA; Malone HM; Lambert JJ
    Trends Pharmacol Sci; 1992 Oct; 13(10):391-7. PubMed ID: 1413088
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.
    Hamon M; Gozlan H; el Mestikawy S; Emerit MB; Bolaños F; Schechter L
    Ann N Y Acad Sci; 1990; 600():114-29; discussion 129-31. PubMed ID: 2252305
    [No Abstract]   [Full Text] [Related]  

  • 65. The functional approach of biological research in psychiatry.
    López-Ibor JJ
    Acta Neurochir Suppl (Wien); 1991; 52():149-53. PubMed ID: 1686520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 5-HT3 receptors.
    Kilpatrick GJ; Bunce KT; Tyers MB
    Med Res Rev; 1990; 10(4):441-75. PubMed ID: 2243511
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacokinetics of 5-HT6 receptor ligands.
    Mancinelli A
    Int Rev Neurobiol; 2010; 94():153-72. PubMed ID: 21081206
    [No Abstract]   [Full Text] [Related]  

  • 68. Pros and cons of 5-HT
    Rahimian R; Fakhfouri G; Zirak MR
    Biomed Pharmacother; 2019 Oct; 118():109301. PubMed ID: 31402188
    [No Abstract]   [Full Text] [Related]  

  • 69. Consensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain.
    Pratt GD; Bowery NG; Kilpatrick GJ; Leslie RA; Barnes NM; Naylor RJ; Jones BJ; Nelson DR; Palacids JM; Slater P
    Trends Pharmacol Sci; 1990 Apr; 11(4):135-7. PubMed ID: 2333665
    [No Abstract]   [Full Text] [Related]  

  • 70. Can 5-HT
    Rojas-Fernandez CH
    Drugs Real World Outcomes; 2014 Dec; 1(1):3-5. PubMed ID: 27747475
    [No Abstract]   [Full Text] [Related]  

  • 71. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task.
    Fontana DJ; Daniels SE; Henderson C; Eglen RM; Wong EH
    Psychopharmacology (Berl); 1995 Aug; 120(4):409-17. PubMed ID: 8539321
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases].
    Broocks A
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.